Security key
29970R303
Evaxion A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)
CUSIP: 29970R303
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
- Total 13F shares
- 119,755
- Total 13F value
- $293,395
- Share change
- -17,306
- SEC-reported price per share
- $2.45
- Number of holders
- 8
- Value change
- -$32,641
- Number of buys
- 1
- Number of sells
- 4
- Shares outstanding
- 6,399,690
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
8
Top holders
8
EVAX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Evaxion A/S SEC filings
Evaxion A/S company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29970R303
Recent filing periods:
Ownership snapshot
Top reported holders of EVAX - Evaxion A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Merck & Co., Inc.
Disclosed value leader
Merck & Co., Inc.
Comparable rows
10/11
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 20%
1 rows are not safely comparable across share classes.
13D/G row: Merck & Co., Inc.
Showing 1-6 of 11 holder rows.
Quick read
Merck & Co., Inc. leads the comparable SEC ownership view at 20%.
10 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Merck & Co., Inc.'s linked filing trail.
Comparable ownership
Top 5
Merck & Co., Inc.
20%
ARMISTICE CAPITAL, LLC
5%
Ikarian Capital, LLC
1.3%
BOOTHBAY FUND MANAGEMENT, LLC
0.37%
XTX Topco Ltd
0.25%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Merck & Co., Inc. |
13D/G
13F
Company
|
20%
|
$105,531,938
63,004,142 shares
|
$0 | 31 Jan 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$506,019
310,441 shares
|
-$536,087 | 31 Mar 2025 |
| Ikarian Capital, LLC |
13F
Company
|
1.3%
|
$148,000
80,000 shares
|
— | 31 Mar 2025 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
0.37%
|
$43,897
23,728 shares
|
— | 31 Mar 2025 |
| XTX Topco Ltd |
13F
Company
|
0.25%
|
$30,120
16,281 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
0.1%
|
$12,056
6,517 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
119,755
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2026 Across Filers
Q1 2026 holders
15
Q2 2025 holders
8
Holder diff
-7
| Investor | Q1 2026 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend